News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Conference News ESC 2023 FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF Shelley Wood August 28, 2023
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News ACC 2022 Managing AF Patients Undergoing PCI—Some Lingering Questions Michael O'Riordan April 12, 2022
News Conference News AHA 2021 GIRAF: Cognitive Outcomes Similar With Dabigatran, Warfarin in Older AF Patients Todd Neale November 14, 2021
News Conference News TCT 2021 Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter? Todd Neale November 06, 2021
News Conference News TCT 2021 PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021
News Conference News ESC 2021 AV Junction Ablation Plus CRT Cuts Deaths in Permanent AF Subset Todd Neale September 01, 2021
News Conference News ESC 2021 Amulet IDE: LAA Occluder Performs Well Against Watchman Todd Neale August 30, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News HRS 2021 J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’ Shelley Wood July 28, 2021
News Conference News ACC 2021 Low 1-Year Stroke Risk After Commercial Watchman Use Todd Neale May 15, 2021
News Conference News EHRA 2021 No Clear Explanation for Benefits of Early Rhythm Control in EAST-AFNET4 Todd Neale April 27, 2021
News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019